Enzyme replacement therapy for Fabry disease: some answers but more questions

Fabry disease (FD) is a multisystem, X-linked disorder of glycosphingolipid metabolism caused by enzyme deficiency of α-galactosidase A. Affected patients have symptoms including acroparesthesias, angiokeratomas, and hypohidrosis. More serious manifestations include debilitating pain and gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfadhel, Majid, Sirrs, Sandra
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061846/
https://www.ncbi.nlm.nih.gov/pubmed/21445281
http://dx.doi.org/10.2147/TCRM.S11987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061846/
https://www.ncbi.nlm.nih.gov/pubmed/21445281
http://dx.doi.org/10.2147/TCRM.S11987

Ejemplares similares